Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 1
2009 2
2010 3
2011 1
2012 2
2013 1
2017 1
2018 3
2019 2
2021 2
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Physical Activity and Asthma.
Pascual S, Dorado S, Urrutia I. Pascual S, et al. Arch Bronconeumol. 2022 Nov;58(11):733-734. doi: 10.1016/j.arbres.2022.03.028. Epub 2022 May 17. Arch Bronconeumol. 2022. PMID: 35718577 English, Spanish. No abstract available.
Effects of smoking bans on passive smoking exposure at work and at home. The European Community respiratory health survey.
Olivieri M, Murgia N, Carsin AE, Heinrich J, Benke G, Bono R, Corsico AG, Demoly P, Forsberg B, Gislason T, Janson C, Jõgi R, Leynaert B, Martínez-Moratalla Rovira J, Norbäck D, Nowak D, Pascual S, Pin I, Probst-Hensch N, Raherison C, Sigsgaard T, Svanes C, Torén K, Urrutia I, Weyler J, Jarvis D, Zock JP, Verlato G. Olivieri M, et al. Among authors: pascual s. Indoor Air. 2019 Jul;29(4):670-679. doi: 10.1111/ina.12556. Epub 2019 Apr 26. Indoor Air. 2019. PMID: 30963644 Free article.
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial.
Köhler W, Engelen M, Eichler F, Lachmann R, Fatemi A, Sampson J, Salsano E, Gamez J, Molnar MJ, Pascual S, Rovira M, Vilà A, Pina G, Martín-Ugarte I, Mantilla A, Pizcueta P, Rodríguez-Pascau L, Traver E, Vilalta A, Pascual M, Martinell M, Meya U, Mochel F; ADVANCE Study Group. Köhler W, et al. Among authors: pascual s. Lancet Neurol. 2023 Feb;22(2):127-136. doi: 10.1016/S1474-4422(22)00495-1. Lancet Neurol. 2023. PMID: 36681445 Clinical Trial.
Association of the CFTR gene with asthma and airway mucus hypersecretion.
Crespo-Lessmann A, Bernal S, Del Río E, Rojas E, Martínez-Rivera C, Marina N, Pallarés-Sanmartín A, Pascual S, García-Rivero JL, Padilla-Galo A, Curto E, Cisneros C, Serrano J, Baiget M, Plaza V; Emerging Asthma Group. Crespo-Lessmann A, et al. Among authors: pascual s. PLoS One. 2021 Jun 4;16(6):e0251881. doi: 10.1371/journal.pone.0251881. eCollection 2021. PLoS One. 2021. PMID: 34086689 Free PMC article.
The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy.
Rodríguez-Pascau L, Vilalta A, Cerrada M, Traver E, Forss-Petter S, Weinhofer I, Bauer J, Kemp S, Pina G, Pascual S, Meya U, Musolino PL, Berger J, Martinell M, Pizcueta P. Rodríguez-Pascau L, et al. Among authors: pascual s. Sci Transl Med. 2021 Jun 2;13(596):eabc0555. doi: 10.1126/scitranslmed.abc0555. Sci Transl Med. 2021. PMID: 34078742
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES).
Pandolfo M, Reetz K, Darling A, Rodriguez de Rivera FJ, Henry PG, Joers J, Lenglet C, Adanyeguh I, Deelchand D, Mochel F, Pousset F, Pascual S, Van den Eede D, Martin-Ugarte I, Vilà-Brau A, Mantilla A, Pascual M, Martinell M, Meya U, Durr A. Pandolfo M, et al. Among authors: pascual s. Neurol Genet. 2022 Nov 1;8(6):e200034. doi: 10.1212/NXG.0000000000200034. eCollection 2022 Dec. Neurol Genet. 2022. PMID: 36524101 Free PMC article.
22 results